4//SEC Filing
Bohen Sean 4
Accession 0001415889-21-004613
CIK 0001750284other
Filed
Sep 28, 8:00 PM ET
Accepted
Sep 29, 7:56 PM ET
Size
9.0 KB
Accession
0001415889-21-004613
Insider Transaction Report
Form 4
Bohen Sean
DirectorPRESIDENT AND CEO
Transactions
- Sale
Common Stock
2021-09-27$30.07/sh−1,085$32,626→ 52,514 total - Exercise/Conversion
Common Stock
2021-09-27$4.82/sh+1,085$5,234→ 53,599 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-09-27−1,085→ 971,316 totalExercise: $4.82Exp: 2030-11-18→ Common Stock (1,085 underlying)
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
- [F2](A) 256,992 of the shares subject to the option vest on September 1, 2021, (B) 2,411 of the shares subject to the option vest on January 1, 2022 and 2,410 of the shares subject to the option vest on January 1 of each of 2023 and 2024 and (C) 23,143 of the shares subject to the option vest on the 1st day of each month (other than on September 1, 2021 and each of January 1, 2022, 2023 and 2024) following September 1, 2021, plus an additional 23 shares on September 1, 2024. Subject to, in each case of (A) - (C) above, the Reporting Person's continuous service on each applicable vesting date. The stock option is early exercisable.
Documents
Issuer
Olema Pharmaceuticals, Inc.
CIK 0001750284
Entity typeother
Related Parties
1- filerCIK 0001831218
Filing Metadata
- Form type
- 4
- Filed
- Sep 28, 8:00 PM ET
- Accepted
- Sep 29, 7:56 PM ET
- Size
- 9.0 KB